Deep Brain Stimulation of the Globus Pallidus in Huntington's Disease
Primary Purpose
Huntington's Disease
Status
Completed
Phase
Phase 1
Locations
Germany
Study Type
Interventional
Intervention
Stimulation
Stimulation
Sponsored by
About this trial
This is an interventional treatment trial for Huntington's Disease focused on measuring Globus pallidus, Huntington's Disease, Deep Brain Stimulation, Movement Disorders
Eligibility Criteria
Inclusion Criteria:
- clinically symptomatic and genetically confirmed Huntington Disease (number of CAG repeats>= 36)
- age: > 18
- moderate stage of the disease (UHDRS motor>= 30)
- predominant movement disorder
- compliance of the patient, stable cognition during a 6 months phase prior to inclusion (MDS>/= 120)
- signed informed consent
Exclusion Criteria:
- advanced disease, precluding the ability to give informed consent
- very early stage of disease causing minor disability
- severe comorbidity that could compromise the life prognostic or preclude general anaesthesia or immunosuppression
- Mattis Dementia Rating Scale < 120
- psychiatric or personality disturbances that might compromise the follow-up
- participation at another trial (in particular transplantation)
- severe cortical atrophy seen on CT and MRI
Sites / Locations
- Functional Neurosurgery and Stereotaxy, Department of Neurosurgery University Hospital Duesseldorf
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
1
2
Arm Description
6 weeks stimulation with GPI (lower caudal two contacts), 4 weeks wash-out, 6 weeks stimulation with GPE (upper cranial two contacts).
6 weeks stimulation with GPE (upper cranial two contacts), 4 weeks wash-out, 6 weeks stimulation with GPI (lower caudal two contacts)
Outcomes
Primary Outcome Measures
Efficacy of stimulation of GPI versus GPR (UHDRS Scale)
Secondary Outcome Measures
Effect of treatment on cognitive functions (neuropsychological tests)
Effects of treatment on electrophysiological tests
Effects of treatment on functional scale (functional ability, dependence scale, TFC)
Progression of disease (motor UHDRS)
Effect of treatment on striatal atrophy (CT Scans)
Full Information
NCT ID
NCT00902889
First Posted
May 14, 2009
Last Updated
September 10, 2012
Sponsor
Heinrich-Heine University, Duesseldorf
1. Study Identification
Unique Protocol Identification Number
NCT00902889
Brief Title
Deep Brain Stimulation of the Globus Pallidus in Huntington's Disease
Official Title
Single Centre (Pilot) Study for Deep Brain Stimulation (DBS) of the Globus Pallidus in Huntington's Disease (HD)
Study Type
Interventional
2. Study Status
Record Verification Date
September 2012
Overall Recruitment Status
Completed
Study Start Date
May 2009 (undefined)
Primary Completion Date
April 2012 (Actual)
Study Completion Date
July 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Heinrich-Heine University, Duesseldorf
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This is a single centre, controlled phase I study, which evaluates safety and efficacy of stimulation of lower caudal two contacts (GPI) vs. upper cranial two contacts (GPE) in Huntington´s disease (HD).
Detailed Description
A total of 6 HD patients will be selected out of an existing larger HD patient cohort upon careful evaluation of the inclusion and exclusion criteria at month 0. Patients will be recruited if no significant cognitive deterioration is observed between month 0 and month 3. The preoperative clinical status will be evaluated twice including the United Huntington Disease Rating Scale (UHDRS), neuropsychological, neurophysiologic and neuroradiological assessments. At 4 weeks postoperatively an extensive evaluation of effects and side effects of every single contact of the bilateral quadripolar electrodes takes place.
All patients will receive a stereotactic placement of bilateral stereotactic insertion of two quadripolar electrodes into the Globus pallidus, two contacts reaching the GPE, two the GPI within both hemispheres. Surgery will be done under general anesthesia, The implantation of the stimulator (Kintera®) will take place in the same procedure. Postoperatively patients will be monitored at three and six months and regularly up to 60 months with a battery of clinical, neuropsychological, psychiatric, neurophysiological and neuroimaging tests.
We expect that this trial will provide a rational basis to conclude about the efficacy, safety, reproducibility and long-term effects of pallidal Deep Brain Stimulation (DBS) on motor symptoms of HD.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Huntington's Disease
Keywords
Globus pallidus, Huntington's Disease, Deep Brain Stimulation, Movement Disorders
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 1
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
6 (Actual)
8. Arms, Groups, and Interventions
Arm Title
1
Arm Type
Experimental
Arm Description
6 weeks stimulation with GPI (lower caudal two contacts), 4 weeks wash-out, 6 weeks stimulation with GPE (upper cranial two contacts).
Arm Title
2
Arm Type
Experimental
Arm Description
6 weeks stimulation with GPE (upper cranial two contacts), 4 weeks wash-out, 6 weeks stimulation with GPI (lower caudal two contacts)
Intervention Type
Procedure
Intervention Name(s)
Stimulation
Other Intervention Name(s)
GPI, GPE
Intervention Description
6 weeks stimulation with GPI (lower caudal two contacts), 4 weeks wash-out, 6 weeks stimulation GPE (upper cranial two contacts)
Intervention Type
Procedure
Intervention Name(s)
Stimulation
Other Intervention Name(s)
GPE, GPI
Intervention Description
6 weeks stimulation with GPE (upper cranial two contacts), 4 weeks wash-out, 6 weeks stimulation with GPI (lower caudal two contacts)
Primary Outcome Measure Information:
Title
Efficacy of stimulation of GPI versus GPR (UHDRS Scale)
Time Frame
3 months after stimulation treatment
Secondary Outcome Measure Information:
Title
Effect of treatment on cognitive functions (neuropsychological tests)
Time Frame
3 months after stimulation treatment
Title
Effects of treatment on electrophysiological tests
Time Frame
3 months after stimulation treatment
Title
Effects of treatment on functional scale (functional ability, dependence scale, TFC)
Time Frame
3 months after stimulation treatment
Title
Progression of disease (motor UHDRS)
Time Frame
12 months after stimulation treatment
Title
Effect of treatment on striatal atrophy (CT Scans)
Time Frame
3 months after stimulation treatment
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
clinically symptomatic and genetically confirmed Huntington Disease (number of CAG repeats>= 36)
age: > 18
moderate stage of the disease (UHDRS motor>= 30)
predominant movement disorder
compliance of the patient, stable cognition during a 6 months phase prior to inclusion (MDS>/= 120)
signed informed consent
Exclusion Criteria:
advanced disease, precluding the ability to give informed consent
very early stage of disease causing minor disability
severe comorbidity that could compromise the life prognostic or preclude general anaesthesia or immunosuppression
Mattis Dementia Rating Scale < 120
psychiatric or personality disturbances that might compromise the follow-up
participation at another trial (in particular transplantation)
severe cortical atrophy seen on CT and MRI
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jan Vesper, Prof. Dr.
Organizational Affiliation
Functional Neurosurgery and Stereotaxy, Department of Neurosurgery
Official's Role
Principal Investigator
Facility Information:
Facility Name
Functional Neurosurgery and Stereotaxy, Department of Neurosurgery University Hospital Duesseldorf
City
Duesseldorf
State/Province
NW
ZIP/Postal Code
40225
Country
Germany
12. IPD Sharing Statement
Citations:
PubMed Identifier
16905252
Citation
Temel Y, Cao C, Vlamings R, Blokland A, Ozen H, Steinbusch HW, Michelsen KA, von Horsten S, Schmitz C, Visser-Vandewalle V. Motor and cognitive improvement by deep brain stimulation in a transgenic rat model of Huntington's disease. Neurosci Lett. 2006 Oct 2;406(1-2):138-41. doi: 10.1016/j.neulet.2006.07.036. Epub 2006 Aug 14.
Results Reference
background
PubMed Identifier
29725840
Citation
Ferrea S, Groiss SJ, Elben S, Hartmann CJ, Dunnett SB, Rosser A, Saft C, Schnitzler A, Vesper J, Wojtecki L; Surgical Approaches Working Group of the European Huntington's Disease Network (EHDN). Pallidal deep brain stimulation in juvenile Huntington's disease: local field potential oscillations and clinical data. J Neurol. 2018 Jul;265(7):1573-1579. doi: 10.1007/s00415-018-8880-1. Epub 2018 May 3.
Results Reference
derived
PubMed Identifier
24878825
Citation
Beste C, Muckschel M, Elben S, J Hartmann C, McIntyre CC, Saft C, Vesper J, Schnitzler A, Wojtecki L. Behavioral and neurophysiological evidence for the enhancement of cognitive control under dorsal pallidal deep brain stimulation in Huntington's disease. Brain Struct Funct. 2015 Jul;220(4):2441-8. doi: 10.1007/s00429-014-0805-x. Epub 2014 May 31.
Results Reference
derived
Learn more about this trial
Deep Brain Stimulation of the Globus Pallidus in Huntington's Disease
We'll reach out to this number within 24 hrs